| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/1997 | EP0553106B1 Anticoccidial and growth promoting polycyclic ether antibiotic |
| 01/22/1997 | EP0550737B1 Controlled release verapamil tablet |
| 01/22/1997 | EP0544802B1 Methods and compositions for treating t-cell mediated diseases |
| 01/22/1997 | EP0542941B1 N-phenyl-benzamides providing protection from the harmful effects of ultraviolet light |
| 01/22/1997 | EP0504290B1 Inhibitors of pneumocystis carinii dihydrofolate reductase |
| 01/22/1997 | EP0481007B1 SLOW RELEASE VEHICLES FOR MINIMIZING SKIN IRRITANCY OF TOPICAL COMPOSITIONS containing retinoids |
| 01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
| 01/22/1997 | CN1141045A Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene) cytidine |
| 01/22/1997 | CN1141044A Antiparasitic agents |
| 01/22/1997 | CN1141043A Non-peptide tachykinin receptor antagonists |
| 01/22/1997 | CN1141042A Enantiomerically pure (+)-liarozole |
| 01/22/1997 | CN1141041A Enantiomerically pure (-)-liarozole |
| 01/22/1997 | CN1141040A 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 01/22/1997 | CN1141039A 4-amino derivatives of 5-substituted mycophenolic acid |
| 01/22/1997 | CN1141038A 5-substituted derivatives of mycophenolic acid |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/22/1997 | CN1140999A Anti-fungal methods and materials |
| 01/22/1997 | CN1140997A Vanadate compounds for the treatment of proliferative disorders metastases and drug resistant tumors |
| 01/22/1997 | CN1140996A Ranitidine and calcium carbonate pharmaceutical combination product |
| 01/22/1997 | CN1140995A Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
| 01/22/1997 | CN1140994A Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 01/22/1997 | CN1140993A Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding |
| 01/22/1997 | CN1140992A Flavin derivatives as anti-viral agents |
| 01/22/1997 | CN1140991A Compositions containing micronized nebivolol |
| 01/22/1997 | CN1140990A Transdermal presentation of nitroglycerin for preventing undesived labour |
| 01/22/1997 | CN1140983A Absorption enhancers for topical pharmaceutical formulations |
| 01/22/1997 | CN1140714A Preparation of cephalosporin antibiotic using syn-isomer of thiazolyl intermediate |
| 01/22/1997 | CN1140710A N,N-diethyl-8,8-dipropyl-2-azaspiro(4,5) decane-2-propanamine dimaleate |
| 01/22/1997 | CN1140709A Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/22/1997 | CN1140708A Synthetic method for lisinopril |
| 01/22/1997 | CN1140606A Ointment for treatment of tinea pedis |
| 01/22/1997 | CN1140600A Preparation of medicament containing rare-earth for dermatomycosis |
| 01/22/1997 | CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs |
| 01/22/1997 | CN1033857C 19-Nor-vitamin D compounds |
| 01/22/1997 | CN1033856C Substituted cinnamic acid and its salt derivatives with central inhibition function |
| 01/22/1997 | CA2154413A1 Fluoxetine pharmaceutical formulations |
| 01/21/1997 | US5596122 Use of disulfonyl methanes for the control of parasites |
| 01/21/1997 | US5596106 Cannabinoid receptor antagonists |
| 01/21/1997 | US5596105 Viricides for treatment of aids htlv virus and autogenesis inhibitors |
| 01/21/1997 | US5596101 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 01/21/1997 | US5596086 Dimers with phosphodiester linkages for hybridization to target rna or dna sequences |
| 01/21/1997 | US5596018 Antiviral agents against aids-causing virus |
| 01/21/1997 | US5596015 Fungicidally active compounds |
| 01/21/1997 | US5596013 Inhibitors of phosphodiesterase type iv and production of tumor necrosis factor |
| 01/21/1997 | US5596012 Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/21/1997 | US5596011 Administering a glutathione enhancing agent |
| 01/21/1997 | US5596009 Fused benzeneoxyacetic acid derivatives |
| 01/21/1997 | US5596007 Lessening withdrawal syndrome for tobacco and nicotine |
| 01/21/1997 | US5596006 Trisubstituted biphenyls |
| 01/21/1997 | US5596004 Methods of inhibiting male infertility |
| 01/21/1997 | US5596003 Piperidinyl thiacyclic derivatives |
| 01/21/1997 | US5596002 Treatment of antibiotic resistant microorganisms |
| 01/21/1997 | US5596000 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 01/21/1997 | US5595999 Guanidine derivatives |
| 01/21/1997 | US5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 01/21/1997 | US5595996 Dihydrotestosterone inhibitor |
| 01/21/1997 | US5595995 Anticarcinogenic agents |
| 01/21/1997 | US5595994 Serotonin agonist |
| 01/21/1997 | US5595993 Antischemic piperazinyl- and piperidinyl-cyclohexanes |
| 01/21/1997 | US5595992 Substituted pyridines and pyrimidines, processes for their preparation and their use as pesticides and fungicides |
| 01/21/1997 | US5595991 Anthelmintic use of nodulisporic acid and analogs thereof |
| 01/21/1997 | US5595990 Treatment of cardiovascular disorders |
| 01/21/1997 | US5595989 Antiinflammatory agents and antidiabetic agents |
| 01/21/1997 | US5595988 Antiallergens |
| 01/21/1997 | US5595987 Cardiovascular disorders |
| 01/21/1997 | US5595986 Stably storable and readily water soluble composition of cephalosporin for injections |
| 01/21/1997 | US5595985 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 01/21/1997 | US5595984 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 01/21/1997 | US5595983 Antagonist action at amino acid receptors, anticonvulsants |
| 01/21/1997 | US5595978 Composition and method for treatment of CMV retinites |
| 01/21/1997 | US5595976 Tetrahydropyran compounds |
| 01/21/1997 | US5595974 Batroxobin with heparin for cardiovascular disorders |
| 01/21/1997 | US5595973 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 01/21/1997 | US5595970 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors |
| 01/21/1997 | US5595877 Methods of producing nucleic acid ligands |
| 01/21/1997 | US5595872 Dna sequences, cells and expression vectors |
| 01/21/1997 | US5595764 Calcium carbonate or sulfate dispersed in petrolatum |
| 01/21/1997 | US5595759 Steroids such as estrogen or progestin for use as contraceptives |
| 01/21/1997 | US5595753 L-arginine |
| 01/21/1997 | US5595732 Polyethylene-protein conjugates |
| 01/21/1997 | US5595730 Lactate dehydrogenase inhibitors in cosmetic compositions |
| 01/21/1997 | US5595722 Transforming growth factor-beta activators |
| 01/21/1997 | CA2123059C Method of lowering blood lipid levels |
| 01/21/1997 | CA2118704C Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists |
| 01/21/1997 | CA2118133C Aminoguanidine spray drying process |
| 01/21/1997 | CA2115045C Composition for curing proliferative skin diseases |
| 01/21/1997 | CA2100918C Oxime derivative |
| 01/21/1997 | CA2033249C Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures |
| 01/21/1997 | CA2028235C Condensed purine derivatives |
| 01/21/1997 | CA2022682C Cycloalkylene azoles, processes for their production and use, and pharmaceutical preparations obtained therefrom |
| 01/21/1997 | CA2009505C Inhibitor of herpesvirus adsorption |
| 01/21/1997 | CA1338867C Derivatives and precursors of captopril and its analogues and methods for preparing captopril and its analogues therefrom |
| 01/21/1997 | CA1338854C Oxygenation of blood substitutes |
| 01/20/1997 | CA2181515A1 4-fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/20/1997 | CA2181308A1 Improving the tolerability of pharmaceutically active beta-amino acids |
| 01/19/1997 | CA2179940A1 Antiallergic composition comprising a phosphoric diester compound |
| 01/19/1997 | CA2154092A1 Skin-cosmetic composition |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001570A1 Colchicine derivatives, the use thereof and formulations containing them |
| 01/16/1997 | WO1997001569A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |